India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...
Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...
DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...
New York startup Helaina, which ferments microbes to create recombinant breast milk proteins, is ushering in a new dawn for ...
Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company.
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...
Thank you to everyone who attended our webinar ‘Antibodies to watch in 2026‘ in association with the journal, mAbs. Below are ...
The Bachelor of Science in Biotechnology at SSc is structured to meet the demands of a fast-changing global biotechnology landscape. The Program offers a flexible major-minor structure, allowing ...
News-Medical.Net on MSN
Targeted uterine mRNA treatment boosts fertility outcomes in mice
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine - which designs nanotechnology-based platforms for clinical translation across specialties - developed a ...
A 10-second act of kindness on a flight linked an Indian scientist with an elderly Japanese couple, creating an unexpected family bond that crossed borders, cultures and years.
Car manufacturers are trialing spider-silk bioleather in seats and interior components, probing the hard limits of automotive-grade performance.
Extracting therapeutic antibodies from biological systems requires stringent purification processes. To reduce costs and accelerate development, novel strategies are essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results